PDB Short entry for 1W6F HEADER TRANSFERASE 17-AUG-04 1W6F TITLE ARYLAMINE N-ACETYLTRANSFERASE FROM MYCOBACTERIUM SMEGMATIS WITH THE TITLE 2 ANTI-TUBERCULAR DRUG ISONIAZID BOUND IN THE ACTIVE SITE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ARYLAMINE N-ACETYLTRANSFERASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 EC: 2.3.1.5; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: ISONIAZID SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM SMEGMATIS; SOURCE 3 ORGANISM_TAXID: 1772; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR: PET28B KEYWDS NAT, TUBERCULOSIS, ACETYLTRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.SANDY,S.HOLTON,E.FULLHAM,E.SIM,M.E.M.NOBLE REVDAT 3 13-DEC-23 1W6F 1 REMARK REVDAT 2 24-FEB-09 1W6F 1 VERSN REVDAT 1 23-FEB-05 1W6F 0 JRNL AUTH J.SANDY,S.HOLTON,E.FULLHAM,E.SIM,M.E.M.NOBLE JRNL TITL BINDING OF THE ANTI-TUBERCULAR DRUG ISONIAZID TO THE JRNL TITL 2 ARYLAMINE N-ACETYLTRANSFERASE PROTEIN FROM MYCOBACTERIUM JRNL TITL 3 SMEGMATIS JRNL REF PROTEIN SCI. V. 14 775 2005 JRNL REFN ISSN 0961-8368 JRNL PMID 15722451 JRNL DOI 10.1110/PS.041163505 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 84.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.100 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.4 REMARK 3 NUMBER OF REFLECTIONS : 107157 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4104 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5584 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2270 REMARK 3 BIN FREE R VALUE SET COUNT : 314 REMARK 3 BIN FREE R VALUE : 0.2860 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8408 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 718 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.53000 REMARK 3 B22 (A**2) : -0.01000 REMARK 3 B33 (A**2) : -1.53000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.187 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.165 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8640 ; 0.019 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 7918 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11770 ; 1.702 ; 1.953 REMARK 3 BOND ANGLES OTHERS (DEGREES): 18174 ; 3.735 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1079 ; 6.989 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1305 ; 0.107 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 9881 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1895 ; 0.011 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1638 ; 0.245 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 8736 ; 0.311 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 4494 ; 0.107 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 625 ; 0.195 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 23 ; 0.248 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 98 ; 0.383 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 23 ; 0.248 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5363 ; 1.168 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 8609 ; 2.129 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3277 ; 2.932 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3161 ; 4.881 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL PLUS MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 1W6F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-AUG-04. REMARK 100 THE DEPOSITION ID IS D_1290020764. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 84858 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.390 REMARK 200 RESOLUTION RANGE LOW (A) : 31.620 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 200 DATA REDUNDANCY : 3.340 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.1700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.62 REMARK 200 R MERGE FOR SHELL (I) : 0.61000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1GX3 CHAIN A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULPHATE, 0.1M MES PH REMARK 280 6.5, 30% PEG MME 5000, PH 6.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 50.60400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.18100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.01950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.18100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 50.60400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.01950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 COULD HAVE A ROLE IN ACETYLATING, AND HENCE REMARK 400 INACTIVATING, THE ANTITUBERCULAR DRUG ISONIAZID. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 GLU B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 MET B 3 REMARK 465 ASP B 4 REMARK 465 LEU B 5 REMARK 465 GLY B 6 REMARK 465 GLU C -2 REMARK 465 SER C -1 REMARK 465 HIS C 0 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 MET C 3 REMARK 465 GLU D -2 REMARK 465 SER D -1 REMARK 465 HIS D 0 REMARK 465 MET D 1 REMARK 465 ALA D 2 REMARK 465 MET D 3 REMARK 465 ASP D 4 REMARK 465 LEU D 5 REMARK 465 THR D 275 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN C 168 O HOH C 2115 1.83 REMARK 500 CG ASP A 161 O HOH A 2161 1.91 REMARK 500 O HOH C 2055 O HOH C 2141 1.97 REMARK 500 O HOH B 2034 O HOH B 2096 1.98 REMARK 500 C GLY B 171 O HOH B 2122 1.99 REMARK 500 CD GLN C 168 O HOH C 2115 2.15 REMARK 500 N GLU B 172 O HOH B 2122 2.16 REMARK 500 OD2 ASP A 161 O HOH A 2161 2.18 REMARK 500 OE1 GLN C 148 O HOH C 2099 2.19 REMARK 500 O HOH D 2024 O HOH D 2073 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 99 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 ASP B 121 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ARG B 170 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 170 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 ASP B 215 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ARG B 218 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ASP B 259 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP C 259 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP D 63 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP D 101 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP D 215 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 62 -64.81 -108.05 REMARK 500 TYR A 69 -167.78 -109.21 REMARK 500 HIS A 151 -108.97 -121.42 REMARK 500 VAL B 62 -69.53 -95.71 REMARK 500 TYR B 69 -161.56 -108.39 REMARK 500 HIS B 151 -108.40 -128.53 REMARK 500 VAL C 62 -68.82 -102.79 REMARK 500 TYR C 69 -165.43 -110.65 REMARK 500 HIS C 151 -107.69 -120.65 REMARK 500 ASP C 161 -49.65 100.37 REMARK 500 ASP C 162 100.19 -59.96 REMARK 500 ALA C 233 148.63 -170.98 REMARK 500 TYR D 69 -166.24 -108.90 REMARK 500 LEU D 141 83.33 -69.67 REMARK 500 ARG D 150 -5.25 -57.77 REMARK 500 HIS D 151 -106.81 -140.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2001 DISTANCE = 5.88 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ISZ A1276 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ISZ B1276 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ISZ C1276 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ISZ D1276 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GX3 RELATED DB: PDB REMARK 900 M. SMEGMATIS ARYLAMINE N-ACETYL TRANSFERASE REMARK 900 RELATED ID: 1W5R RELATED DB: PDB REMARK 900 X-RAY CRYSTALLOGRAPHIC STRCUTURE OF A C70Q MYCOBACTERIUM SMEGMATIS REMARK 900 N-ARYLAMINE ACETYLTRANSFERASE DBREF 1W6F A -2 0 PDB 1W6F 1W6F -2 0 DBREF 1W6F A 1 275 UNP O86309 NAT_MYCSM 1 275 DBREF 1W6F B -2 0 PDB 1W6F 1W6F -2 0 DBREF 1W6F B 1 275 UNP O86309 NAT_MYCSM 1 275 DBREF 1W6F C -2 0 PDB 1W6F 1W6F -2 0 DBREF 1W6F C 1 275 UNP O86309 NAT_MYCSM 1 275 DBREF 1W6F D -2 0 PDB 1W6F 1W6F -2 0 DBREF 1W6F D 1 275 UNP O86309 NAT_MYCSM 1 275 SEQRES 1 A 278 GLU SER HIS MET ALA MET ASP LEU GLY GLY TYR LEU THR SEQRES 2 A 278 ARG ILE GLY LEU ASP GLY ARG PRO ARG PRO ASP LEU GLY SEQRES 3 A 278 THR LEU HIS ALA ILE VAL ALA ALA HIS ASN ARG SER ILE SEQRES 4 A 278 PRO PHE GLU ASN LEU ASP PRO LEU LEU GLY ILE PRO VAL SEQRES 5 A 278 ALA ASP LEU SER ALA GLU ALA LEU PHE ALA LYS LEU VAL SEQRES 6 A 278 ASP ARG ARG ARG GLY GLY TYR CYS TYR GLU HIS ASN GLY SEQRES 7 A 278 LEU LEU GLY TYR VAL LEU GLU GLU LEU GLY PHE GLU VAL SEQRES 8 A 278 GLU ARG LEU SER GLY ARG VAL VAL TRP MET ARG ALA ASP SEQRES 9 A 278 ASP ALA PRO LEU PRO ALA GLN THR HIS ASN VAL LEU SER SEQRES 10 A 278 VAL ALA VAL PRO GLY ALA ASP GLY ARG TYR LEU VAL ASP SEQRES 11 A 278 VAL GLY PHE GLY GLY GLN THR LEU THR SER PRO ILE ARG SEQRES 12 A 278 LEU GLU ALA GLY PRO VAL GLN GLN THR ARG HIS GLU PRO SEQRES 13 A 278 TYR ARG LEU THR ARG HIS GLY ASP ASP HIS THR LEU ALA SEQRES 14 A 278 ALA GLN VAL ARG GLY GLU TRP GLN PRO LEU TYR THR PHE SEQRES 15 A 278 THR THR GLU PRO ARG PRO ARG ILE ASP LEU GLU VAL GLY SEQRES 16 A 278 SER TRP TYR VAL SER THR HIS PRO GLY SER HIS PHE VAL SEQRES 17 A 278 THR GLY LEU THR VAL ALA VAL VAL THR ASP ASP ALA ARG SEQRES 18 A 278 TYR ASN LEU ARG GLY ARG ASN LEU ALA VAL HIS ARG SER SEQRES 19 A 278 GLY ALA THR GLU HIS ILE ARG PHE ASP SER ALA ALA GLN SEQRES 20 A 278 VAL LEU ASP ALA ILE VAL ASN ARG PHE GLY ILE ASP LEU SEQRES 21 A 278 GLY ASP LEU ALA GLY ARG ASP VAL GLN ALA ARG VAL ALA SEQRES 22 A 278 GLU VAL LEU ASP THR SEQRES 1 B 278 GLU SER HIS MET ALA MET ASP LEU GLY GLY TYR LEU THR SEQRES 2 B 278 ARG ILE GLY LEU ASP GLY ARG PRO ARG PRO ASP LEU GLY SEQRES 3 B 278 THR LEU HIS ALA ILE VAL ALA ALA HIS ASN ARG SER ILE SEQRES 4 B 278 PRO PHE GLU ASN LEU ASP PRO LEU LEU GLY ILE PRO VAL SEQRES 5 B 278 ALA ASP LEU SER ALA GLU ALA LEU PHE ALA LYS LEU VAL SEQRES 6 B 278 ASP ARG ARG ARG GLY GLY TYR CYS TYR GLU HIS ASN GLY SEQRES 7 B 278 LEU LEU GLY TYR VAL LEU GLU GLU LEU GLY PHE GLU VAL SEQRES 8 B 278 GLU ARG LEU SER GLY ARG VAL VAL TRP MET ARG ALA ASP SEQRES 9 B 278 ASP ALA PRO LEU PRO ALA GLN THR HIS ASN VAL LEU SER SEQRES 10 B 278 VAL ALA VAL PRO GLY ALA ASP GLY ARG TYR LEU VAL ASP SEQRES 11 B 278 VAL GLY PHE GLY GLY GLN THR LEU THR SER PRO ILE ARG SEQRES 12 B 278 LEU GLU ALA GLY PRO VAL GLN GLN THR ARG HIS GLU PRO SEQRES 13 B 278 TYR ARG LEU THR ARG HIS GLY ASP ASP HIS THR LEU ALA SEQRES 14 B 278 ALA GLN VAL ARG GLY GLU TRP GLN PRO LEU TYR THR PHE SEQRES 15 B 278 THR THR GLU PRO ARG PRO ARG ILE ASP LEU GLU VAL GLY SEQRES 16 B 278 SER TRP TYR VAL SER THR HIS PRO GLY SER HIS PHE VAL SEQRES 17 B 278 THR GLY LEU THR VAL ALA VAL VAL THR ASP ASP ALA ARG SEQRES 18 B 278 TYR ASN LEU ARG GLY ARG ASN LEU ALA VAL HIS ARG SER SEQRES 19 B 278 GLY ALA THR GLU HIS ILE ARG PHE ASP SER ALA ALA GLN SEQRES 20 B 278 VAL LEU ASP ALA ILE VAL ASN ARG PHE GLY ILE ASP LEU SEQRES 21 B 278 GLY ASP LEU ALA GLY ARG ASP VAL GLN ALA ARG VAL ALA SEQRES 22 B 278 GLU VAL LEU ASP THR SEQRES 1 C 278 GLU SER HIS MET ALA MET ASP LEU GLY GLY TYR LEU THR SEQRES 2 C 278 ARG ILE GLY LEU ASP GLY ARG PRO ARG PRO ASP LEU GLY SEQRES 3 C 278 THR LEU HIS ALA ILE VAL ALA ALA HIS ASN ARG SER ILE SEQRES 4 C 278 PRO PHE GLU ASN LEU ASP PRO LEU LEU GLY ILE PRO VAL SEQRES 5 C 278 ALA ASP LEU SER ALA GLU ALA LEU PHE ALA LYS LEU VAL SEQRES 6 C 278 ASP ARG ARG ARG GLY GLY TYR CYS TYR GLU HIS ASN GLY SEQRES 7 C 278 LEU LEU GLY TYR VAL LEU GLU GLU LEU GLY PHE GLU VAL SEQRES 8 C 278 GLU ARG LEU SER GLY ARG VAL VAL TRP MET ARG ALA ASP SEQRES 9 C 278 ASP ALA PRO LEU PRO ALA GLN THR HIS ASN VAL LEU SER SEQRES 10 C 278 VAL ALA VAL PRO GLY ALA ASP GLY ARG TYR LEU VAL ASP SEQRES 11 C 278 VAL GLY PHE GLY GLY GLN THR LEU THR SER PRO ILE ARG SEQRES 12 C 278 LEU GLU ALA GLY PRO VAL GLN GLN THR ARG HIS GLU PRO SEQRES 13 C 278 TYR ARG LEU THR ARG HIS GLY ASP ASP HIS THR LEU ALA SEQRES 14 C 278 ALA GLN VAL ARG GLY GLU TRP GLN PRO LEU TYR THR PHE SEQRES 15 C 278 THR THR GLU PRO ARG PRO ARG ILE ASP LEU GLU VAL GLY SEQRES 16 C 278 SER TRP TYR VAL SER THR HIS PRO GLY SER HIS PHE VAL SEQRES 17 C 278 THR GLY LEU THR VAL ALA VAL VAL THR ASP ASP ALA ARG SEQRES 18 C 278 TYR ASN LEU ARG GLY ARG ASN LEU ALA VAL HIS ARG SER SEQRES 19 C 278 GLY ALA THR GLU HIS ILE ARG PHE ASP SER ALA ALA GLN SEQRES 20 C 278 VAL LEU ASP ALA ILE VAL ASN ARG PHE GLY ILE ASP LEU SEQRES 21 C 278 GLY ASP LEU ALA GLY ARG ASP VAL GLN ALA ARG VAL ALA SEQRES 22 C 278 GLU VAL LEU ASP THR SEQRES 1 D 278 GLU SER HIS MET ALA MET ASP LEU GLY GLY TYR LEU THR SEQRES 2 D 278 ARG ILE GLY LEU ASP GLY ARG PRO ARG PRO ASP LEU GLY SEQRES 3 D 278 THR LEU HIS ALA ILE VAL ALA ALA HIS ASN ARG SER ILE SEQRES 4 D 278 PRO PHE GLU ASN LEU ASP PRO LEU LEU GLY ILE PRO VAL SEQRES 5 D 278 ALA ASP LEU SER ALA GLU ALA LEU PHE ALA LYS LEU VAL SEQRES 6 D 278 ASP ARG ARG ARG GLY GLY TYR CYS TYR GLU HIS ASN GLY SEQRES 7 D 278 LEU LEU GLY TYR VAL LEU GLU GLU LEU GLY PHE GLU VAL SEQRES 8 D 278 GLU ARG LEU SER GLY ARG VAL VAL TRP MET ARG ALA ASP SEQRES 9 D 278 ASP ALA PRO LEU PRO ALA GLN THR HIS ASN VAL LEU SER SEQRES 10 D 278 VAL ALA VAL PRO GLY ALA ASP GLY ARG TYR LEU VAL ASP SEQRES 11 D 278 VAL GLY PHE GLY GLY GLN THR LEU THR SER PRO ILE ARG SEQRES 12 D 278 LEU GLU ALA GLY PRO VAL GLN GLN THR ARG HIS GLU PRO SEQRES 13 D 278 TYR ARG LEU THR ARG HIS GLY ASP ASP HIS THR LEU ALA SEQRES 14 D 278 ALA GLN VAL ARG GLY GLU TRP GLN PRO LEU TYR THR PHE SEQRES 15 D 278 THR THR GLU PRO ARG PRO ARG ILE ASP LEU GLU VAL GLY SEQRES 16 D 278 SER TRP TYR VAL SER THR HIS PRO GLY SER HIS PHE VAL SEQRES 17 D 278 THR GLY LEU THR VAL ALA VAL VAL THR ASP ASP ALA ARG SEQRES 18 D 278 TYR ASN LEU ARG GLY ARG ASN LEU ALA VAL HIS ARG SER SEQRES 19 D 278 GLY ALA THR GLU HIS ILE ARG PHE ASP SER ALA ALA GLN SEQRES 20 D 278 VAL LEU ASP ALA ILE VAL ASN ARG PHE GLY ILE ASP LEU SEQRES 21 D 278 GLY ASP LEU ALA GLY ARG ASP VAL GLN ALA ARG VAL ALA SEQRES 22 D 278 GLU VAL LEU ASP THR HET ISZ A1276 10 HET ISZ B1276 10 HET ISZ C1276 10 HET ISZ D1276 10 HETNAM ISZ 4-(DIAZENYLCARBONYL)PYRIDINE HETSYN ISZ ISONIAZID; TUBAZID; RIMITSID; ISONICOTINYLHYDRAZINE; HETSYN 2 ISZ LANIZID; NYDRAZID FORMUL 5 ISZ 4(C6 H5 N3 O) FORMUL 9 HOH *718(H2 O) HELIX 1 1 ASP A 4 ILE A 12 1 9 HELIX 2 2 ASP A 21 ILE A 36 1 16 HELIX 3 3 ASN A 40 LEU A 45 1 6 HELIX 4 4 SER A 53 VAL A 62 1 10 HELIX 5 5 TYR A 69 LEU A 84 1 16 HELIX 6 6 PRO A 185 HIS A 199 1 15 HELIX 7 7 SER A 202 GLY A 207 1 6 HELIX 8 8 SER A 241 ARG A 252 1 12 HELIX 9 9 LEU A 257 ALA A 261 5 5 HELIX 10 10 ASP A 264 VAL A 272 1 9 HELIX 11 11 GLY B 7 GLY B 13 1 7 HELIX 12 12 ASP B 21 ILE B 36 1 16 HELIX 13 13 ASN B 40 LEU B 45 1 6 HELIX 14 14 SER B 53 VAL B 62 1 10 HELIX 15 15 TYR B 69 GLY B 85 1 17 HELIX 16 16 PRO B 185 HIS B 199 1 15 HELIX 17 17 SER B 202 GLY B 207 1 6 HELIX 18 18 SER B 241 ARG B 252 1 12 HELIX 19 19 LEU B 257 ALA B 261 5 5 HELIX 20 20 ASP B 264 VAL B 272 1 9 HELIX 21 21 LEU C 5 ILE C 12 1 8 HELIX 22 22 ASP C 21 ILE C 36 1 16 HELIX 23 23 ASN C 40 LEU C 45 1 6 HELIX 24 24 SER C 53 VAL C 62 1 10 HELIX 25 25 TYR C 69 GLY C 85 1 17 HELIX 26 26 PRO C 185 HIS C 199 1 15 HELIX 27 27 SER C 202 GLY C 207 1 6 HELIX 28 28 SER C 241 ARG C 252 1 12 HELIX 29 29 ASP C 256 ALA C 261 5 6 HELIX 30 30 ASP C 264 VAL C 272 1 9 HELIX 31 31 GLY D 6 ILE D 12 1 7 HELIX 32 32 ASP D 21 ILE D 36 1 16 HELIX 33 33 ASN D 40 LEU D 45 1 6 HELIX 34 34 SER D 53 VAL D 62 1 10 HELIX 35 35 TYR D 69 LEU D 84 1 16 HELIX 36 36 PRO D 185 HIS D 199 1 15 HELIX 37 37 SER D 202 GLY D 207 1 6 HELIX 38 38 SER D 241 ARG D 252 1 12 HELIX 39 39 ASP D 256 ALA D 261 5 6 HELIX 40 40 ASP D 264 VAL D 272 1 9 SHEET 1 AA10 PHE A 38 GLU A 39 0 SHEET 2 AA10 THR A 209 VAL A 213 -1 O ALA A 211 N PHE A 38 SHEET 3 AA10 ALA A 217 ARG A 222 -1 O TYR A 219 N VAL A 212 SHEET 4 AA10 ASN A 225 ARG A 230 -1 O ASN A 225 N ARG A 222 SHEET 5 AA10 ALA A 233 PHE A 239 -1 O ALA A 233 N ARG A 230 SHEET 6 AA10 ALA B 233 PHE B 239 -1 O THR B 234 N ARG A 238 SHEET 7 AA10 ASN B 225 ARG B 230 -1 O LEU B 226 N ILE B 237 SHEET 8 AA10 ARG B 218 ARG B 222 -1 O ARG B 218 N HIS B 229 SHEET 9 AA10 THR B 209 VAL B 213 -1 O VAL B 210 N LEU B 221 SHEET 10 AA10 PHE B 38 GLU B 39 -1 O PHE B 38 N ALA B 211 SHEET 1 AB 8 ILE A 139 ARG A 140 0 SHEET 2 AB 8 TYR A 124 VAL A 126 -1 O LEU A 125 N ILE A 139 SHEET 3 AB 8 GLN A 108 ALA A 116 -1 O LEU A 113 N VAL A 126 SHEET 4 AB 8 GLU A 87 VAL A 95 -1 O GLU A 87 N ALA A 116 SHEET 5 AB 8 GLU A 172 PHE A 179 -1 O THR A 178 N ARG A 94 SHEET 6 AB 8 ASP A 162 VAL A 169 -1 O HIS A 163 N PHE A 179 SHEET 7 AB 8 TYR A 154 HIS A 159 -1 O ARG A 155 N ALA A 166 SHEET 8 AB 8 VAL A 146 GLN A 147 -1 O GLN A 147 N TYR A 154 SHEET 1 BA 8 ILE B 139 ARG B 140 0 SHEET 2 BA 8 TYR B 124 VAL B 126 -1 O LEU B 125 N ILE B 139 SHEET 3 BA 8 GLN B 108 ALA B 116 -1 O LEU B 113 N VAL B 126 SHEET 4 BA 8 GLU B 87 VAL B 95 -1 O GLU B 87 N ALA B 116 SHEET 5 BA 8 GLU B 172 PHE B 179 -1 O THR B 178 N ARG B 94 SHEET 6 BA 8 ASP B 162 VAL B 169 -1 O HIS B 163 N PHE B 179 SHEET 7 BA 8 TYR B 154 HIS B 159 -1 O ARG B 155 N ALA B 166 SHEET 8 BA 8 VAL B 146 GLN B 147 -1 O GLN B 147 N TYR B 154 SHEET 1 CA10 PHE C 38 GLU C 39 0 SHEET 2 CA10 THR C 209 VAL C 213 -1 O ALA C 211 N PHE C 38 SHEET 3 CA10 ALA C 217 ARG C 222 -1 O TYR C 219 N VAL C 212 SHEET 4 CA10 ASN C 225 ARG C 230 -1 O ASN C 225 N ARG C 222 SHEET 5 CA10 ALA C 233 ARG C 238 -1 O ALA C 233 N ARG C 230 SHEET 6 CA10 THR D 234 PHE D 239 -1 O THR D 234 N ARG C 238 SHEET 7 CA10 ASN D 225 ARG D 230 -1 O LEU D 226 N ILE D 237 SHEET 8 CA10 ALA D 217 ARG D 222 -1 O ARG D 218 N HIS D 229 SHEET 9 CA10 THR D 209 VAL D 213 -1 O VAL D 210 N LEU D 221 SHEET 10 CA10 PHE D 38 GLU D 39 -1 O PHE D 38 N ALA D 211 SHEET 1 CB 8 ILE C 139 ARG C 140 0 SHEET 2 CB 8 TYR C 124 VAL C 126 -1 O LEU C 125 N ILE C 139 SHEET 3 CB 8 GLN C 108 ALA C 116 -1 O LEU C 113 N VAL C 126 SHEET 4 CB 8 GLU C 87 VAL C 95 -1 O GLU C 87 N ALA C 116 SHEET 5 CB 8 GLU C 172 PHE C 179 -1 O THR C 178 N ARG C 94 SHEET 6 CB 8 ASP C 162 VAL C 169 -1 O HIS C 163 N PHE C 179 SHEET 7 CB 8 TYR C 154 HIS C 159 -1 O ARG C 155 N ALA C 166 SHEET 8 CB 8 VAL C 146 GLN C 147 -1 O GLN C 147 N TYR C 154 SHEET 1 DA 8 ILE D 139 ARG D 140 0 SHEET 2 DA 8 TYR D 124 VAL D 126 -1 O LEU D 125 N ILE D 139 SHEET 3 DA 8 GLN D 108 ALA D 116 -1 O LEU D 113 N VAL D 126 SHEET 4 DA 8 GLU D 87 VAL D 95 -1 O GLU D 87 N ALA D 116 SHEET 5 DA 8 GLU D 172 PHE D 179 -1 O THR D 178 N ARG D 94 SHEET 6 DA 8 ASP D 162 VAL D 169 -1 O HIS D 163 N PHE D 179 SHEET 7 DA 8 PRO D 153 HIS D 159 -1 O PRO D 153 N GLN D 168 SHEET 8 DA 8 VAL D 146 GLN D 148 -1 O GLN D 147 N TYR D 154 SITE 1 AC1 9 PHE A 38 TYR A 69 CYS A 70 TYR A 71 SITE 2 AC1 9 VAL A 95 THR A 109 PHE A 130 PHE A 204 SITE 3 AC1 9 HOH A2248 SITE 1 AC2 10 PHE B 38 TYR B 69 CYS B 70 TYR B 71 SITE 2 AC2 10 VAL B 95 THR B 109 GLY B 129 PHE B 130 SITE 3 AC2 10 PHE B 204 HOH B2196 SITE 1 AC3 11 PHE C 38 TYR C 69 CYS C 70 TYR C 71 SITE 2 AC3 11 VAL C 95 THR C 109 GLY C 129 PHE C 130 SITE 3 AC3 11 PHE C 204 HOH C2172 HOH C2173 SITE 1 AC4 9 PHE D 38 TYR D 69 CYS D 70 TYR D 71 SITE 2 AC4 9 VAL D 95 THR D 109 GLY D 129 PHE D 130 SITE 3 AC4 9 PHE D 204 CRYST1 101.208 106.039 140.362 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009881 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009430 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007124 0.00000